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ABSTRACT
ISWI is an evolutionarily conserved ATP-dependent chromatin remodeling factor playing central roles
in DNA replication, RNA transcription, and chromosome organization. The variety of biological functions
dependent on ISWI suggests that its activity could be highly regulated. Our group has previously isolated
and characterized new cellular activities that positively regulate ISWI in Drosophila melanogaster. To identify
factors that antagonize ISWI activity we developed a novel in vivo eye-based assay to screen for genetic
suppressors of ISWI. Our screen revealed that ISWI interacts with an evolutionarily conserved network of
cellular and nuclear factors that escaped previous genetic and biochemical analyses.
THE eukaryotic cell has evolved regulatory mecha-nisms to induce structural changes to chromatin
in response to environmental and cellular stimuli.
Chromatin covalent modifiers catalyze specific post-
translational modifications of the histones’ amino- and
carboxy-terminal tails (Kouzarides 2007), while chro-
matin remodeling complexes use the energy of ATP
hydrolysis to change nucleosome positions or to incor-
porate histone variants into chromatin (Eberharter
and Becker 2004; Saha et al. 2006). These chromatin
modifications, occurring without a change in DNA
sequence, set different chromatin functional states and
constitute the epigenetic marks of our genome (Imhof
2006; Martin and Zhang 2007; Sala and Corona
2009). Although it is expected that a cross talk should
exist between ATP-dependent remodelers and covalent
modifiers of chromatin, little is known about how these
activities are coordinated and integrated with each other
in complex chromatin signaling pathways (Strahl and
Allis 2000; Jenuwein and Allis 2001).
ISWI is the catalytic subunit of several ATP-dependent
chromatin remodeling complexes, highly conserved
during evolution and essential for cell viability (Corona
and Tamkun 2004). ISWI-containing complexes play
central roles in DNA replication, gene expression, and
chromosome organization (Dirscherl and Krebs 2004).
ISWI uses the energy of ATP hydrolysis to catalyze nu-
cleosome spacing and sliding reactions (Corona and
Tamkun 2004). In Drosophila, loss of ISWI function
causes global transcription defects and leads to dramatic
alterations in higher-order chromatin structure, including
the apparent decondensation of both mitotic and in-
terphase chromosomes (Deuring et al. 2000; Corona
et al. 2007). Recent findings indicate that ISWI controls
chromosome compaction in vivo, in part through its abil-
ity to promote the association of the linker histone H1 with
chromatin (Corona et al. 2007; Siriaco et al. 2009).
In vitro and in vivo studies carried out in several model
organisms have also shown the involvement of ISWI-
containing complexes in a variety of nuclear functions
including telomere silencing, stem cell self-renewal,
neural morphogenesis, and epigenetic reprogramming
occurring during nuclear transfer in animal cloning
(Dirscherl and Krebs 2004; Xi and Xie 2005; Parrish
et al. 2006). Inactivation of ISWI also interferes with
the ras pathway (Andersen et al. 2006), and loss of ISWI
function seems to be associated with a subset of mela-
notic tumors and the human multisystemic disease
Williams–Beuren syndrome (Mellor 2006).
The variety of functions associated with ISWI is prob-
ably connected to the ability of other cellular and nu-
clear factors to regulate its ATP-dependent chromatin
remodeling activity (Corona et al. 2002; Ferreira et al.
2007; Hogan and Varga-Weisz 2007). Due to the broad
spectrum of functions played by ISWI in vivo, it is likely
that chromatin factors, nuclear enzymatic activities,
and a variety of histone modifications may influence
its activity in vivo. To identify new regulators of ISWI
function, we developed an eye-based assay to identify
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ISWI genetic interactors in the higher eukaryote Dro-
sophila melanogaster (Corona et al. 2004). Loss of ISWI
function, by eye-specific misexpression of the dominant
negative allele ISWIK159R, produces catalytically inactive
ISWI that is incorporated into native complexes, giving
rise to rough and reduced eye phenotypes in otherwise
healthy flies (Deuring et al. 2000; Burgio et al. 2008).
In a previous study, we used this in vivo eye assay to
conduct an unbiased genetic screen for mutations in
genes that dominantly modify phenotypes resulting
from the misexpression of ISWIK159R in the eye (Burgio
et al. 2008).
The screen produced the first genetic interaction
map for the ATP-dependent chromatin remodeler
ISWI in a higher eukaryote (Burgio et al. 2008). The
characterization of the network of factors we isolated
revealed unanticipated roles for ISWI in the cell as well
as novel mechanisms by which its activity could be
regulated (Burgio et al. 2008). Interestingly, one class
of mutants isolated in the ISWIK159R screen included
chromatin components and nuclear enzymatic activities
that could regulate ISWI function by covalently modify-
ing chromatin factors or ISWI itself (Burgio et al. 2008;
Sala et al. 2008). The biochemical characterization of
the genetic interactions recovered between ISWIK159R
and genes encoding for chromatin covalent modifiers,
established that eye-based genetic screens in flies could
be a powerful tool for the in vivo dissection of chromatin-
remodeling signaling pathways occurring in the nucleus
(Corona et al. 2004; Armstrong et al. 2005; Burgio
et al. 2008; Sala and Corona 2009). Moreover, the
ISWIK159R screen established that ISWI function could
be modulated in vivo by a variety of cellular factors that
have escaped previous biochemical analyses (Burgio
et al. 2008).
The nonsaturating ISWIK159R F1 screen was designed
to specifically isolate enhancers of ISWI (Burgio et al.
2008). To identify novel factors working in antagonism
with ISWI, we developed a new in vivo assay that allowed
us to screen for genetic suppressors of eye phenotypes
caused by true loss-of-function ISWI alleles. We took
advantage of the Ey-Gal4, UAS-Flip (EGUF) approach
to produce flies with eyes composed exclusively of
mitotic clones that have lost ISWI function (Stowers
and Schwarz 1999). Loss of ISWI in the eye caused
reduced rough eyes, eye color variegation, and loss of
cell identity. We employed the ISWI-EGUF eye pheno-
types to set up a dominant modifier screen to isolate
factors antagonizing ISWI activity in vivo. Employing
classic gene network bioinformatics analysis, we com-
bined the results of our screen with those obtained in
two others screens conducted in Drosophila and in
Caenorhabditis elegans, where an ISWI allele and its worm
ortholog were isolated (Andersen et al. 2006; Parrish
et al. 2006). The combination of genetic and bioinfor-
matics approaches employed resulted in the identifica-
tion of an evolutionarily conserved network of modifiers
of ISWI eye phenotypes, which included several poten-
tial antagonists of ISWI function. Our analysis revealed
new roles for ISWI in cell cycle progression as well as
unanticipated mechanisms by which its activity could be
regulated, shedding new light into the evolutionarily
conserved physiological function of ISWI family mem-
bers in cell cycle regulation.
MATERIALS AND METHODS
Drosophila stocks and genetic crosses: Flies were raised at
25 on K12 medium (Genovese and Corona 2007). Unless
otherwise stated, strains were obtained from Bloomington,
Szeged, and Drosophila Genetic Resource Center Stock
Centers and are described in FlyBase (http://www.flybase.org).
ISWI-EGUF eye characterization: The EGUF approach
(Stowers and Schwarz 1999) was employed to obtain, by
mitotic recombination, flies with eyes entirely composed
of homozygous wild-type, ISWI2, brm2, and kis1 clones (ISWI-
EGUF). The control wild-type EGUF adults FRT42D,1/FRT42D,
GMR-hid; EGUF/1 were obtained by crossing yw; P{neoFRT}42D
males with yw; P{neoFRT}42D,GMR-hid2R,CL2R,y1/CyO; EGUF
virgins. ISWI-EGUF adults FRT42D, ISWI2/FRT42D, GMR-hid;
EGUF/1 were obtained by crossing yw; P{neoFRT}42D,ISWI2,sp/
SM5,Cy,sp males with yw; P{neoFRT}42D,GMR-hid2R,CL2R,y1/
CyO; EGUF virgins. ISWI-EGUF adults bearing a copy of wild-
type ISWI (Deuring et al. 2000), FRT42D, ISWI2/FRT42D,
GMR-hid; ISWI1/EGUF were obtained by crossing yw;
P{neoFRT}42D,ISWI2,sp/1;P{w1,ISWI1}/1 males with yw;
P{neoFRT}42D,GMR-hid2R,CL2R,y1/CyO;EGUF virgins. ISWI-
EGUF adults bearing a copy of the enzymatic inactive ISWIK159R
(Deuring et al. 2000), FRT42D, ISWI2/FRT42D, GMR-hid;
ISWIK159R/EGUF were obtained by crossing yw;P{neoFRT}42-
D,ISWI2,sp/1;P{w1,ISWIK159R}/1males with yw; P{neoFRT}42D,
GMR-hid2R,CL2R,y1/CyO;EGUF virgins. brm-EGUF adults
EGUF/1; FRT79B, brm2/FRT79B, GMR-hid were obtained by
crossing yw; P{neoFRT}79B,brm2/TM6,Hu,Tb males with yw;
EGUF/CyO; P{neoFRT}79B,GMR-hid3R,CL3R,y1/TM3,Sb virgins.
kis-EGUF adults FRT40A, kis1/FRT40A, GMR-hid; 1/EGUF
were obtained by crossing yw; P{neoFRT}40A,kis1/CyO males
with yw; P{neoFRT}40A,GMR-hid2L,CL2L,y1/CyO; EGUF virgins.
ISWI-EGUF adults bearing a copy of the acf1[1] allele (Fyodorov
et al. 2004), FRT42D, ISWI2/FRT42D, GMR-hid; acf1[1]/EGUF
were obtained by crossing yw; P{neoFRT}42D,ISWI2,sp/1;
acf1[1]/1 males with yw; P{neoFRT}42D,GMR-hid2R,CL2R,y1/
CyO;EGUF virgins. ISWI-EGUF adults bearing a copy of the
E(bx)Nurf301-2 allele (Badenhorst et al. 2002), FRT42D, ISWI2/
FRT42D, GMR-hid; E(bx)Nurf301–2/EGUF were obtained by cross-
ing yw; P{neoFRT}42D,ISWI2,sp/1; E(bx)Nurf301-2/1 males with
yw; P{neoFRT}42D,GMR-hid2R,CL2R,y1/CyO; EGUF virgins.
ISWI-EGUF PiggyBac genetic screen: New PiggyBac in-
sertions were generatad by crossing small batches of 20
pHer{3xP3-ECFP,atub-piggyBacK10} jumpstarter males with
20 yw,pBac{3xP3-EYFP,p-tTA-K10}; P{neoFRT}42D,ISWI2,sp/
CyO mutator bearing virgins. In the F1, males yw,pBac{3xP3-
EYFP,p-tTA-K10}; P{neoFRT}42D,ISWI2,sp/pHer{3xP3-ECFP,a-
tub-piggyBacK10} carrying the ISWI2 allele and both mutator
and jumpstarter elements, recognizable by the double CFP/YFP
eye fluorescence and the absence of the Cy marker, were
crossed with isogenic w1118 virgins. In the F2, single males w1118;
P{neoFRT}42D,ISWI2,sp/pBac{3xP3-EYFP,p-tTA-K10} if the mu-
tator hopped on the second chromosome or w1118; P{neo-
FRT}42D,ISWI2,sp/1; pBac{3xP3-EYFP,p-tTA-K10}/1 } if the
mutator hopped on the third chromosome, recognizable by the
presence of the YFP and absence of the CFP eye fluorescence,
were crossed with yw; P{neoFRT}42D,GMR-hid2R,CL2R,y1/CyO;
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EGUF virgins. In the F3, males and females P{neoFRT}42D,GMR-
hid2R,CL2R,y1/P{neoFRT}42D,ISWI2,pBac{3xP3-EYFP,p-tTA-
K10},sp; EGUF/1 for second chromosome mutator insertions
and P{neoFRT}42D,GMR-hid2R,CL2R,y1/P{neoFRT}42D,ISWI2,sp;
EGUF/pBac{3xP3-EYFP,p-tTA-K10} for third chromosome mutator
insertions were scored for their ability to dominantly modify
(enhance or suppress) ISWI-EGUF eye phenotypes. Flies carrying
only one FRT42D site linked with the GMR-hid transgene could
be easily recognized because they cannot undergo eye-specific
mitotic recombination, thus generating slightly pigmented adult
eyes without ommatidia (Figure 2A) (Stowers and Schwarz
1999). Interacting mutator insertions were retested and balanced
on both chromosomes. The PiggyBac mutator line pBac{3xP3-
EYFP, p-tTA-K10} (Horn et al. 2003), containing the tetracycline
transactivator gene (tTA) instead of the yeast GAL4 transactivator,
was employed to avoid interference with the EGUF system.
ISWI-EGUF EP genetic screen: The EP collection on the
third chromosome (Rorth et al. 1998) was tested by cross-
ing males carrying a balanced or unbalanced EP insertion
with yw; P{neoFRT}42D,ISWI2,sp/CyO virgins. In the F1, yw;
P{neoFRT}42D,ISWI2,sp/1;EP/1 males, recognizable by the
loss of the Cy and EP balancer markers, were crossed with
yw; P{neoFRT}42D,GMR-hid2R,CL2R,y1/CyO; EGUF virgins.
In the F2, male and female yw; P{neoFRT}42D,ISWI2,sp/
P{neoFRT}42D,GMR-hid2R,CL2R,y1; EGUF/EP were scored
for their ability to dominantly modify (enhance or suppress)
ISWI-EGUF eye phenotypes.
ISWI-EGUF genetic screen scoring system: The ISWI-EGUF
eye phenotypes are highly penetrant (100%; n ¼ 1000) and
show a very low expressivity (, 15% of progeny show
phenotypes less or more severe than the standard ISWI-EGUF
eye phenotypes; n ¼ 1000). Nevertheless, both the PiggyBac
and the EP ISWI-EGUF screens were conducted in F3 and F2,
respectively (see Figure 2), to increase the chance to identify
true ISWI-EGUF modifiers. A PiggyBac or an EP insertion was
considered an Enhancer of ISWI [En(ISWI)] if .50% of the
experimental class showed an eye with a more severe pheno-
type (reduced eye size and increased roughness), when
compared to the control ISWI-EGUF eye. A PiggyBac or an EP
insertion was considered a Suppressor of ISWI [Su(ISWI)] if
.50% of the experimental class showed an eye with a less
severe phenotype (increased eye size and reduced roughness),
when compared to the control ISWI-EGUF eye. PiggyBac and EP
insertions giving in the experimental class both En(ISWI) and
Su(ISWI) were termed bimodal, Bi(ISWI).
ISWI-EGUF secondary screens: To eliminate false ISWI-EGUF
interactors, distinct secondary screens were conducted on the
basis of the type of insertions (PiggyBac vs. EP transposons), the
chromosome arm hit (2L, 2R, 3L, or 3R), and the type of
interaction class scored (enhancer vs. suppressor). PiggyBac
En(ISWI)’s mapping the 2L, 3L, and 3R chromosomes were
tested for their inability to cause eye defects in the absence of an
FRT42D, ISWI2 chromosome (supporting information, File S1
and Figure S4). PiggyBac En(ISWI) and Su(ISWI) mapping the
2R chromosome, because of the presence of the FRT42D sites,
produce eyes with the 2R chromosome in homozygosis.
Therefore, false En(ISWI)’s were eliminated because they
failed to enhance ISWI-EGUF eyes in the presence of
an ectopic copy of the wild-type ISWI1 transgene (Figure
S4). On the other hand, false Su(ISWI)’s were identified by
their inability to suppress ISWI-EGUF eyes in the presence of an
extra copy of the GMR-hid transgene not linked to the FRT42D
recombination site (Figure S4). Finally, En(ISWI) and Su(ISWI)
isolated with the EP screen were eliminated for their failure to
enhance or suppress ISWI-EGUF eye phenotypes in the absence of
the FRT42D, ISWI2 chromosome (Figure S4).
iPCR and candidate allele analysis: We mapped ISWI-EGUF
modifiers to 99 potential protein-coding loci (Table S1),
combining iPCR data available in FlyBase (www.flybase.org)
for the EP interacting insertions with the iPCR sequencing
data we generated for the PiggyBac interactors, using standard
protocols (www.fruitfly.org/about/methods/inverse.pcr.html).
Some ISWI-EGUF modifiers (i.e., mbf1, ttk, eff, stg, and cpo) were
validated by testing other alleles of these genes, available from
public stock centers, using the genetic screen scheme used for
testing EP insertions. Mutations in genes corresponding to
‘‘neuronal morphogenesis,’’ ‘‘multiple cell fate,’’ and ‘‘connect-
ing’’ nodes were obtained from public stock centers and tested
for their ability to interact in the ISWI-EGUF eye assay, using the
genetic screen scheme used for testing EP insertions, and in the
ISWIK159R eye assay according to Burgio et al. (2008).
Bioinformatic and cell cycle analyses: For the BioGrid
analysis (Breitkreutz et al. 2008), each En(ISWI), Su(ISWI),
and Bi(ISWI) ISWI-EGUF interaction was associated with a
single gene on the basis of the insertion DNA sequence data
available in FlyBase (www.flybase.org) and the iPCR analysis we
conducted on the PiggyBac insertions. The gene ontology data
and all the genetic and physical interactions existing between
the ISWI-EGUF modifiers were obtained from the BioGrid
website (www.thebiogrid.org) and were represented in a
graphical format using the Osprey software (Breitkreutz
et al. 2003) (http://biodata.mshri.on.ca/osprey/servlet/Index).
For Gene Ontology (GO) analysis the FatiGO data mining tool
(Al-Shahrour et al. 2007) and the latest gene annotation and
Gene Ontology provided by FlyBase were used. The C. elegans
genes isolated in the multiple cell fate screening (Andersen et al.
2006) were converted to fly orthologs using the WormBase
database (www.wormbase.org).
For the GO analysis the gene annotation and the Gene
Ontology provided by FlyBase were used with Ontologizer
(www.ohloh.net/p/ontologizer) to determine overrepre-
sented GO terms. The parent–child method of Ontologizer,
which takes into account the parent–child relationships of the
GO hierarchy, was applied and the P-values were adjusted
using Westfall–Young single-step multiple testing correction. A
corrected P-value threshold of 0.1 was used as a cutoff for
reporting significant matches. To compute statistical signifi-
cance of the frequencies of GO-component terms hyper-
geometric distributions were calculated on the basis of the
occurrence of the indicated terms and corrected for multiple
testing by the Bonferroni correction method.
Cell cycle profiles from imaginal discs and brain cells were
obtained according to Collesano and Corona (2007), using
a BD FACSCanto flow cytometer (BD Biosciences), with a laser
wavelength set at 488 nm (6000 events were recorded for
each cell cycle profile). Cell cycle profiles were quantitatively
analyzed using the ModFit software. Homozygous ISWI2,
wunPBacF48 and ISWI2, caspPBacG75a brains and total imaginal discs
used for the cell cycle analysis were dissected from third instar
larvae, obtained from stocks balanced with the T(2:3),CyO,
Tb balancer and selected for the absence of the Tb marker.
Imaginal eye discs subjected to cell cycle analysis were
obtained by crossing ISWI2; eyGAL4/T(2:3), CyO, Tb virgins
with ISWI2; eyGAL4/T(2:3), CyO, Tb or ISWI2; effEP3627/T(2:3),
CyO, Tb or ISWI2; ttkEP3314/T(2:3), CyO, Tb or ISWI2; mbf1EP3684/
T(2:3), CyO, Tb males.
RESULTS AND DISCUSSION
An in vivo assay to identify factors antagonizing ISWI
activity: Suppressors of ISWI function are a very impor-
tant class of genes to identify, as they may give us a
complete picture of factors regulating chromatin re-
modeling reactions in vivo. We previously showed that
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the misexpression of ISWIK159R in the eye-antennal discs
caused defects that could be enhanced by null alleles of
ISWI, indicating that ISWIK159R eye phenotypes resulted
from the specific reduction of ISWI function in the eye.
However, due to the conditions used (cross temperature
and choice of Gal4 driver), we generated mild eye
phenotypes that probably prevented us from identifying
suppressors of ISWIK159R (Burgio et al. 2008). On the
other hand, we could not formally exclude that the
misexpression of ISWIK159R might also have had some
unspecific dominant effects that compromised eye de-
velopment, preventing us from recovering suppressors
of ISWIK159R (Burgio et al. 2008).
Because of the limitations derived from the previous
eye assay and the potential interfering effect of the
dominant negative allele ISWIK159R, we decided to de-
velop a new in vivo eye assay. To isolate an antagonist of
ISWI function we generated flies with eyes composed
exclusively of clones that had lost ISWI activity using the
EGUF approach (Stowers and Schwarz 1999). The
EGUF method uses the eye-specific eyGAL4 driver in
combination with the UAS-FLP transgene to express the
site-specific recombinase FLP in mitotically active eye
precursor cells. When homologous chromosomes con-
taining FRT’s recombination sites are present in these
cells, FLP-mediated site-specific mitotic recombination
occurs. Since one of the two FRT recombination sites is
distally linked with the dominant photoreceptor cell
lethal transgene GMR-hid, after mitotic recombination
all photoreceptor cells bearing one or two copies of
GMR-hid will die because of the eye-specific expression
of the cell death gene hid during metamorphosis. Thus,
this technique allows the generation of adult eyes that
are homozygous for a specific mutation in an otherwise
heterozygous adult fly (Stowers and Schwarz 1999).
Using the EGUF approach we generated flies with eyes
homozygous for the ISWI2 null allele (compare Figure
1A with 1B) (Deuring et al. 2000). Loss of ISWI in the
eye by the EGUF approach caused reduced rough eyes,
eye color variegation, and loss of cell identity (ISWI-
EGUF eye phenotype) (compare Figure 1B). The ISWI-
EGUF eye phenotypes are specifically caused by the
mitotic recombination of the ISWI2 allele occurring in
the developing eye-antennal discs (Figure S1) and are
characterized by defects in the retina structure consist-
ing of the loss of ommatidia boundaries and orientation
and a reduced number of photoreceptors (Figure 1B
and Figure S2). Indeed, some photoreceptors appear to
Figure 1.—Loss of ISWI function by the EGUF approach causes specific eye phenotypes. Drosophila adult eyes obtained with the
EGUF mitotic clonal approach (Stowers and Schwarz 1999) bear in homozygosis a wild-type 2R chromosome (A), an ISWI2 allele
(B), an ISWI2 allele in the presence of one extra copy of the wild-type ISWI1 gene (C), or a copy of ISWIK159R defective in its ATPase
activity (D), a brm2 (E) or kis1 allele (F), an ISWI2 allele in the presence of one copy of acf1[1] (G), or E(bx)Nurf301-2 (H) alleles. The
white arrowhead indicates the eye color variegation, while the black arrowhead indicates loss of cell identity defects in which
bristles grow in eye territories normally occupied by photoreceptors. The ISWI-EGUF eye phenotype is caused by the progressive
depletion, during eye development, of the ISWI mRNA/protein pool present before mitotic recombination in ISWI2 heterozygous
mother cells. As a consequence, ISWI progressive loss of activity during eye development, occurring after mitotic recombination,
could be accelerated by loss of factors positively regulating its activity, like acf1 and E(bx), thus explaining the enhancement of ISWI-
EGUF eye defects we observe. On the other hand, the presence of an extra copy of the wild-type ISWI1 gene can complement eye
defects caused by the recombination-dependent ISWI genetic loss.
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undergo a process of degeneration probably contribut-
ing to the observed ommatidia loss in the ISWI-EGUF
adult eye (Figure S2).
The ISWI-EGUF eye phenotypes are very specific for
the loss of ISWI activity since they can be fully suppressed
by an ectopic copy of wild-type ISWI 1 (Deuring et al.
2000), under the control of its natural promoter (Figure
1C), but not by a copy of ISWIK159R (Deuring et al. 2000)
defective in its ATPase activity (Figure 1D). These data
strongly suggest that the ISWI-EGUF eye defects are
specifically caused by the loss of ISWI enzymatic activity
and that ISWI-EGUF eye phenotypes could be in princi-
ple suppressed. Interestingly, we observed that loss of
the brm chromatin remodeling factor, the Drosophila
ortholog of the yeast SWI2/SNF2 protein, and kis,
another ATP-dependent chromatin remodeling factor
(Becker and Horz 2002), results in eye phenotypes
distinct from ISWI-EGUF (compare Figure 1B with 1E
and 1F), highlighting the specificity of the ISWI-EGUF
phenotype. Remarkably, mutations in acf1 and E(bx),
two genes encoding for known physical interactors of
ISWI (Badenhorst et al. 2002; Corona and Tamkun
2004; Fyodorov et al. 2004), enhance ISWI-EGUF eye
defects (compare Figure 1B with 1G and 1H), further
indicating that the ISWI-EGUF phenotypes are specific
for loss of ISWI activity and that they could also be used
to recover dominant enhancers.
Previous work has shown that individuals that are
homozygous for the ISWI2 allele survive until late larval
development, due to the high maternal contribution of
ISWI (Corona et al. 2007; Burgio et al. 2008). In-
terestingly, loss of ISWI function in very late developing
larvae (21 days) also caused global polytene chromo-
some condensation defects (Figure S3), highly reminis-
cent of chromosome condensation defects observed
when misexpressing ISWIK159R (Corona et al. 2007;
Burgio et al. 2008). Therefore, we reasoned that similar
chromatin organization defects in ISWI2 null cells in the
eye discs could also directly or indirectly contribute to
the observed ISWI-EGUF eye defects, thus facilitating the
genetic isolation of factors antagonizing ISWI chroma-
tin remodeling activity.
A genetic screen for suppressors of ISWI: We de-
cided to exploit the ISWI-EGUF eye phenotypes as an
in vivo assay to conduct a dominant modifier genetic
screen to isolate factors suppressing ISWI activity. The
rationale of this screen was that mutations in genes
that dominantly modify ISWI-EGUF eye phenotypes
are likely to encode for regulators or effectors of ISWI
function in vivo. To circumvent the known limitations
of P-element-based mutagenesis (i.e., preference to
integrate into hotspots) we decided to use a PiggyBac-
based insertional mutagenesis approach (Hacker
et al. 2003). To identify and stably establish novel
insertion lines without the need of balancers, we used
two independent and distinguishable fluorescent
markers to track a PiggyBac mutator line (marked with
YFP) and a jumpstarter (marked with CFP), carrying a
source of PiggyBac transposase (Figure 2A) (Hacker
et al. 2003). Since each strain can be followed indepen-
dently by fluorescence of adult fly eyes (Figure 2A), we
did not use balancer chromosomes to track new inser-
tions during the screening process. In particular, the
dominant YFP fluorescence was used as a visible marker
to identify novel insertions in both larval and adult stages,
thus facilitating stock keeping. Furthermore, the Piggy-
Bac transposon insertions also marked the mutated gene,
thus helping us in mapping and cloning the mutations of
interest.
To identify potential loss-of-function interactions
suppressing ISWI-EGUF eye phenotypes, we screened
2000 newly generated insertions of the transposable
mutator element PiggyBac (Figure 2, A and B) (Hacker
et al. 2003). After crossing the jumpstarter and the mutator
lines, flies carrying both elements as well as the FRT42D,
ISWI2 chromosome were identified on the basis of the
eye-specific CFP and YFP fluorescence and the absence
of the CyO balancer (Figure 2, A and B). In the next
generation, the CFP-marked jumpstarter was crossed
out to allow the stable inheritance of the YFP-marked
autosomal insertion (Figure 2, A and B). Finally, males
carrying second and third chromosome stable PiggyBac
insertions were crossed with the EGUF line to score for
ISWI interactions (Figure 2, A and B). In a second
complementary approach, we screened potential gain-
of-function interactions using the EP collection on
the third chromosome that may lead to the GAL4-
dependent overexpression of the gene downstream
the insertion site (Rorth et al. 1998) (Figure 2C). All
PiggyBac and EP interacting lines were retested and
rescreened in specific secondary screens to eliminate
false positives (Figure S4).
Combining iPCR data for the EP interacting inser-
tions available on FlyBase with iPCR sequencing data we
generated for the PiggyBac interactors, we mapped
ISWI-EGUF modifiers to 99 potential protein-coding loci
(Table S1, A and B). We found 21 PiggyBac (1% of
total insertions screened) and 78 EP (8% of total inser-
tions screened) interactors (Table S1, A and B). Our
scoring strategy defined three different classes of
modifiers of ISWI-EGUF eye phenotypes: enhancers,
En(ISWI), suppressors, Su(ISWI), and few mutations giv-
ing a bimodal population comprising both enhancers
and suppressors in the same progeny that we called
Bi(ISWI) (Figure 3A and Table S1, A and B). One easy
way to explain the bimodal type of interaction is that we
scored two independent mutations, one enhancing and
the other suppressing, coming from the same EP line
tested. Indeed, for the bimodal interactions we isolated
we confirmed that the presence of two independent
mutations (probably arising from a second nonanno-
tated segregating independent insertion or lesion) were
likely responsible for the bimodal genetic interaction
initially scored (Table S1 C).
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To understand the biological processes regulated by
the ISWI-EGUF modifiers we isolated, we conducted a
GO analysis employing the latest protein annotations
available on FlyBase. Our GO analysis revealed that ISWI
interacts with a network of cellular and nuclear factors
involved in a variety of biological functions not pre-
viously linked with known ISWI activities (Figure 3B).
Furthermore, to gain an integrated view of the
interaction network potentially existing between the
genes isolated in our screen, we annotated the known
genetic and physical interactions existing among the
ISWI-EGUF modifiers with the help of the BioGrid
database, containing the information of all known
physical and genetic interactions reported for a variety
of model organisms, including D. melanogaster (http://
www.thebiogrid.org). Our analysis revealed that some
of the ISWI-EGUF modifiers are known to interact with
each other, forming small interaction networks, empha-
sizing the functional correlation existing between some
of the factors isolated in our screen (Figure 3).
Finally we compared the list of ISWI-EGUF modifiers
we recovered with the one we obtained with our pre-
vious ISWIK159R eye assay (Burgio et al. 2008). This
analysis revealed that the two screens resulted in the
isolation of a number of common modifiers (25%;
Figure 3C, Table S1 B, and Figure S5). However, the
ISWI-EGUF screen allowed us also to isolate cellular and
nuclear factors that have escaped from our previous
ISWIK159R genetic approach, including several Su(ISWI)’s
(Figure 3C and Table S1 B).
ISWI interacts with factors antagonizing its activity
in vivo: One of the main goals of the ISWI-EGUF screen
was to isolate factors encoding activities that could
antagonize ISWI function in vivo. Our genetic screen
resulted in the isolation of several modifiers of ISWI-
EGUF eye phenotypes behaving as suppressors (Figure
Figure 2.—ISWI-EGUF genetic screen strategy. (A) The use of distinguishable fluorescent transformation markers in the adult
eyes allows us to follow the mutator (YFP) and the jumpstarter (CFP) elements independently. (B and C) Crossing scheme for
the identification of new PiggyBac mutator (B) and third chromosome EP insertions (C) dominantly modifying ISWI-EGUF eye
phenotypes. For both the PiggyBac mutator and the EP screen, in the absence of mitotic recombination, the presence of the
GMR-hid transgene generates adult eyes without ommatidia but slightly pigmented (Stowers and Schwarz 1999), allowing their
unambiguous distinction from the mitotic recombinant experimental class. The presence of w1-marked EP insertions allowed the
scoring of the mitotic recombinant experimental class in the EP screen. Mut, mutator; Jump, jumpstarter.
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3A and Table S1). As expected, some ISWI suppressors
are associated with enzymatic activities regulating chro-
matin function like trx, E(Pc), the poly-ADP-ribose poly-
merase tankyrase, and the class I ubiquitin-conjugating
(E2) enzyme effete (eff) (Figures 3A and 4A). Indeed, eff
is thought to play essential roles in telomere function
(Cenci et al. 2005). Eff biochemically interacts with the
zinc-finger transcriptional repressor encoded by the
tramtrack gene (ttk) (Badenhorst et al. 1996; Tang et al.
1997), whose mutations also suppress ISWI-EGUF eye
phenotypes (Figures 3A and 4A). Another gene that
suppresses the ISWI-EGUF eye is multiprotein bridging
factor 1 (mbf1) (Figures 3A and 4A). Mbf1 is a highly con-
served protein in archaea and eukaryotes (de Koning
et al. 2009) that allows cells to maintain adequate activity
of the cell proliferation transcription factor AP-1 under
oxidative stress (Jindra et al. 2004). Interestingly, Mbf1
also enhances transcription by forming a bridge be-
tween distinct regulatory DNA-binding proteins and
the TATA-box-binding protein (TBP) (de Koning et al.
2009). Moreover, Mbf1 is predicted to have a methyl-
CpG binding domain (inferred from sequence similar-
ity with UniProtKB: Q9Z2E1) that would in principle
allow the selective binding of methylated cytosine/
guanine DNA, potentially linking ISWI activity with
DNA methylation in flies. To validate the specificity of
some of the genetic interactions identified, we tested
whether other alleles of ttk, eff, and mbf1 also behaved
as Su(ISWI)’s. Indeed, some of the alleles tested for ttk,
eff, and mbf1 suppress ISWI-EGUF eye phenotypes (Fig-
ure 4B).
ISWI interacts with an evolutionarily conserved
network of cellular factors: In at least two other screens
independently conducted in flies and worms ISWI was
Figure 3.—ISWI genetically interacts with a wide range of cellular components. The 99 potential protein-coding loci corre-
sponding to ISWI-EGUF dominant modifiers are clustered in concentric circles as nodes, colored according to their interaction
class (A), current gene ontology (GO) categories, as indicated in the key (B), and their intersection with ISWI interactors isolated
in the ISWIK159R screen (Burgio et al. 2008) (C). The edges represent known physical and genetic interactions identified with the
experimental system indicated in the key.
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picked up as a genetic interactor. An RNA interference
screen identified ISWI as one of the factors involved in
the proper morphogenesis of Drosophila sensory neu-
ron dendrites (Parrish et al. 2006). In another genetic
screen for factors regulating the expression of vulval
cell fates in C. elegans, mutations in ISW-1, the worm
ortholog of fly ISWI, suppressed the multivulva pheno-
type caused by the hyperactivation of the Ras pathway
(Andersen et al. 2006).
To gain some insights into the evolutionarily con-
served network of regulation of ISWI we decided to
identify known functional connections existing between
genes scored in the four different ISWI-based genetic
screens (ISWIK159R, ISWI-EGUF, the fly neuronal morpho-
genesis, and the worm multiple cell fate screens). We
used the BioGrid to search for known genetic or
physical interactions existing between the genes identi-
fied in the fly neuronal morphogenesis and the worm
multiple cell fate screens and the modifier genes
we picked in both the ISWI-EGUF and the ISWIK159R
eye screens (Andersen et al. 2006; Parrish et al. 2006;
Burgio et al. 2008). Our analysis identified 1 big (93
nodes) and 12 small networks comprising ISWI genetic
interactors isolated in the four different genetic screens
analyzed (Figure 5A, Figure S6, and Table S2, A–D).
Next, to verify whether the 12 small networks (compris-
ing a total of 33 nodes with a network size ranging from 2
to 5 nodes) were functionally related to each other, we
again queried the BioGrid to search for factors bridging
any of the genes belonging to the 12 networks. In-
terestingly, this analysis identified 41 connecting nodes
linking the 33 genes included in the 12 small networks,
defining a second big network (Figure 5B, Figure S6,
and Table S2 E). The bioinformatic analysis allowed us
to predict that ISWI genetically and physically interacted
with a series of factors, in part shared among the four
different genetic screens analyzed (purple, yellow,
green, and blue nodes in Figure 5) and in part novel
(red nodes in Figure 5), that may have escaped ISWI-
based screens.
To verify whether the predicted interacting nodes
were true ISWI genetic interactors, we tested multiple
alleles for each of the neuronal morphogenesis and the
worm multiple cell fate screens and the connecting
nodes, for their ability to interact in the ISWI-EGUF or
the ISWIK159R eye assays. Remarkably, alleles of genes
corresponding to 63% of the neuronal morphogenesis,
90% of the multiple cell fate, and 50% of the connecting
nodes genetically interacted with at least one of the
ISWI-EGUF or ISWIK159R eye assays (Figure 5C and Table
S3). Our data strongly indicate that the nucleosome
remodeling factor ISWI functionally interacts with an
evolutionarily conserved network of cellular factors,
predicted by the gene network analysis we conducted.
Loss of ISWI causes cell cycle defects that can be
suppressed by Su(ISWI)’s: A GO analysis on the evolu-
tionarily conserved network of ISWI interactors sug-
gested a significant enrichment of regulators of cell
cycle and signal transduction (i.e., Stg, Abl, Rbf1, E2F, and
Ras85D) (Figure 5 and Table S2). In particular, an
analysis conducted with Ontologizer (to quantify GO
terms representation) showed that cell cycle regulation is
an overrepresented category within the combined
interacting nodes shown in Figure 5 (P-value ¼ 0.03;
Table S2). Loss of ISWI activity has been linked to
different aspect of cell cycle regulation connected, for
example, to the development of melanotic tumors
(Mellor 2006), the regulation of the germline stem
cell self-renewal, and the Rb pathway (Dirscherl and
Krebs 2004; Xi and Xie 2005; Parrish et al. 2006).
Moreover, our data show that loss of ISWI in the eye-
antennal discs causes an eye phenotype characterized by
patches of ommatidia that are missing, disorganized,
dedifferentiated, or variegated (Figure 1B and Figure
S2; Burgio et al. 2008), suggesting a possible role for
ISWI in cell viability and the control of differentiation.
To directly test whether loss of ISWI causes cell cycle
defects, we analyzed isolated cell populations from
imaginal discs and larval brains, obtained ex vivo
from wild-type (w1118) and ISWI mutant larvae using a
new method we recently developed (Collesano and
Corona 2007). We decided to analyze imaginal discs
because they contain highly proliferating cells and
also because we conducted the two ISWI screens in
Figure 4.—Loss of ISWI function in the eye can be domi-
nantly suppressed by mutations in mbf1, ttk, eff, and wun. (A)
Eye phenotypes resulting from an eye homozygous for ISWI2
(ISWI-EGUF eye) carrying an EP insertion mapping the mbf1,
ttk, and eff genes or a PiggyBac insertion in the wun gene. (B)
To validate the genetic interactions we scored, other alleles
mapping mbf1, ttk, eff, and wun were tested in the ISWI-EGUF
eye assay.
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eye-antennal imaginal discs. However, we also extended
our analysis to brain tissues to test potential ISWI
cell cycle defects also in highly differentiating cells
(Collesano and Corona 2007). Isolated cell popula-
tions were directly analyzed by flow cytometry and cell
cycle profiles were subjected to quantification (Figure
S7) (Collesano and Corona 2007).
Our analysis revealed significant differences in cell
cycle profiles between wild-type and ISWI mutant larvae.
Loss of ISWI in total imaginal or in eye imaginal discs
caused a marked decrease of both G1 and G2/M peaks as
well as a dramatic increase of the pre-G1 peak (red and
purple arrows in Figure 6, B and C; Figure S7, E and
G). We reasoned that the increase in the pre-G1 peak
reflects DNA fragmentation due to cell death likely
caused by a G1 or G2/M block caused by ISWI mutant
disc defects (i.e., alterations in chromosome condensa-
tion, replication, or gene expression). Interestingly, the
pre-G1 defect is specific for proliferating ISWI mutant
discs and it is not detected in ISWI mutant differentiat-
ing brain cells that are a mixture of differentiated and
cycling cells, with a significant contribution of cells in G1
(Figure 6A and Figure S7 C). On the other hand, ISWI
mutant brain cells show a reproducible approximately
Figure 5.—Evolutionarily conserved network of regulation of ISWI. BioGrid analysis is shown of known genetic and physical
interactions existing between the genes identified in the fly ‘‘neuronal morphogenesis’’ and the worm ‘‘multiple cell fate’’ screens
and the modifier genes we picked in both the ISWI-EGUF and the ISWIK159R eye screens (Andersen et al. 2006; Parrish et al. 2006;
Burgio et al. 2008). Our analysis predicted (A) 1 big and (B) 12 small interaction networks comprising ISWI genetic interactors
isolated in the four different genetic screens analyzed, linked by ‘‘connecting’’ nodes corresponding to interactors not isolated in
previous ISWI related screens. The big network comprises 93 nodes while the 12 small networks are constituted of 33 original
nodes and 41 connecting new nodes. (C) Alleles of genes corresponding to 63% of the neuronal morphogenesis, 90% of the
multiple cell fate, and 50% of the connecting nodes genetically interacted with the ISWI-EGUF or the ISWIK159R eye assays. These
interaction frequencies are much greater than the frequencies of ISWI interaction we normally get with eye-based screens (usually
in the 1–11% range), suggesting that the gene network analysis we conducted increased our ability to predict ISWI interactors.
The edges represent known physical and genetic interactions identified with the experimental system indicated in the key. ISWI-
EGUF or ISWIK159R interacting genes are highlighted in boldface type and have a bigger node size.
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twofold increase in the G2/M cell population and a
shorter S phase when compared to wild type (green and
blue arrows in Figure 6A and Figure S7 B), probably
reflecting a G2/M block or a faster S phase [as previously
shown in SL2 cells silenced for the ISWI regulator Acf1
(Fyodorov et al. 2004)].
Our cell cycle analysis suggests that highly proliferat-
ing cells tend to be more sensitive to loss of ISWI activity
while differentiating cells resist ISWI loss by shortening
the S phase and accumulating in G2/M. To check if ISWI
cell cycle defects could be suppressed by some of the
Su(ISWI)’s we identified in the ISWI-EGUF screen, we
conducted the same analysis on double ISWI, Su(ISWI)
mutants that survived to third instar larval stage, where
brains and imaginal discs could be dissected. For these
reasons, we limited our cell cycle analysis to the EP lines:
effEP3627, ttkEP3314, mbf1EP3684, and the newly generated
PiggyBac insertion wunPBacF48, a gene encoding for a
lipid phosphate phosphatase guiding germ cell migra-
tion (Table S1 A and Figure 4). As an internal positive
control to evaluate the level of cell cycle suppression we
could get in the double ISWI, Su(ISWI) mutant discs and
brains, we also included in our analysis an allele of casp
(caspPBacG75a), a false positive Su(ISWI) we isolated in our
ISWI-EGUF screen. The casp gene encodes for a homolog
of the mammalian Fas-associating factor 1, an apoptotic
signaling factor that acts downstream of the Fas signal
transduction pathway. Due to its role in promoting apo-
ptosis, loss of casp is expected to suppress cell death and
cell cycle defects linked to apoptotic signaling present in
ISWI mutant cells.
Indeed, the false positive Su(ISWI) caspPBacG75a mutant
suppressed the shortening of the S phase observed in
ISWI mutant brain cells (Figure 6A and Figure S7 B).
Interestingly, wunPBacF48 Su(ISWI) also suppressed the
ISWI S-phase defect (Figure 6A and Figure S7 B);
however, both caspPBacG75a and wunPBacF48 failed to suppress
the ISWI G2/M increase observed in differentiating brain
cells (Figure 6A and Figure S7 B). These results indicate
that the specific S-phase shortening and the G2/M
increase observed in brain cells are very likely indepen-
dent noncoupled ISWI defects.
Figure 6.—Cytofluorimetric analysis of ISWI mutant cells. Cell populations derived ex vivo from wild-type and ISWI mutant
neuroblasts (A) and total imaginal (B) and eye-antennal imaginal (C) discs were analyzed by flow cytometry. ISWI imaginal disc
cells showed a significant decrease of G1 and G2/M peaks (red arrows) and an increase in the pre-G1 peak (purple arrow). On the
other hand, when compared to their wild-type counterpart, ISWI mutant neuroblasts showed a small but reproducible increase in
the G2/M peak (green arrow) and a faster S phase (blue arrow). These cell cycle defects can be in part or completely suppressed by
some of the Su(ISWI)’s we isolated.
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Interestingly, wunPBacF48 and caspPBacG75a can also sup-
press ISWI pre-G1 defects observed in imaginal disc cells
(Figure S7, D and E) and restore a cell cycle profile
similar to wild type (Figure 6B). Remarkably, while the
Su(ISWI) EP lines effEP3627 and ttkEP3314 in the presence of
the eyGAL4 driver weakly suppress eye disc-specific ISWI
pre-G1 and G1–G2/M defects, the mbf1EP3684 Su(ISWI)
strongly suppresses these defects (Figure S7, F and G;
Figure 6C).
Concluding remarks: The ISWI-EGUF screen allowed
us to isolate new ISWI genetic interactors that increased
our understanding of the complex network of factors
regulating ISWI nuclear signaling pathways. The ISWI-
EGUF screen revealed that ISWI interacts with an
evolutionarily conserved network of cellular and nu-
clear factors that escaped previous genetic and bio-
chemical analyses, indicating the participation of ISWI
in a variety of biological processes not linked to date
with known ISWI functions. Moreover, the combination
of gene network bioinformatics tools with classic fly
genetics approaches has been instrumental to isolate
some of the factors that might have been missed in the
not saturating ISWI-based screens. The unexpected
functional interactions we found between ISWI and
factors playing central roles in cell cycle regulation have
a high potential to shed light on the mechanistic aspects
of cell cycle progression directly or indirectly regulated
by ISWI and more generally by chromatin remodelers.
Although the molecular basis of the genetic antagonism
existing between ISWI and the variety of modifiers we
identified will need further characterization and many
of the isolated modifiers may act indirectly (i.e., by
regulating the perdurance, the expression, or regula-
tors of ISWI), we believe that the network of ISWI
enhancers and suppressors we isolated represents an
invaluable selected cohort of genes that could be
potentially assayed in any biological process where an
ISWI-dependent functional assay is available.
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FILE S1 
SUPPORTING MATERIALS AND METHODS 
 
Salivary gland chromosomes cytology. Polytene chromosome structure analysis, on ISWI1/ISWI2 21 days old male salivary 
gland nuclei, was conducted by crossing w/Y; ISWI1, Bc/ SM5, Cy males to y w; ISWI2/T(2:3) CyO;TM6B, Tb virgin females at 
18°C. 21 days old ISWI1/ISWI2 trans-heterozygous male larvae were recognized by their yellow mouth hooks, the presence of the 
dominant Bc marker and the absence of the Tb marker. Polytene chromosome preparations and DAPI stainings were conducted 
according to previously published protocols (CORONA et al. 2004). 
 
Eye imaginal discs Analysis. Immunofluorescence on GFPnls-marked ISWI2/ISWI2 homozygous eye disc nuclei were 
conducted in larvae obtained by crossing males from the FIG line (FRT42D, ISWI, GFP), generated by classic recombination 
(XU and RUBIN 1993): w/Y; P{neoFRT}42D,ISWI2, P{Ubi-GFP(S65T)nls}/CyO with yw; P{neoFRT}42D,GMR-
hid2R,CL2R,y+/CyO; EGUF virgins. Heterozygous and homozygous GFPnls-marked wild type eye disc nuclei were obtained from 
yw; P{neoFRT}42D, P{Ubi-GFP(S65T)nls}/CyO larvae or from larvae obtained by crossing yw; P{neoFRT}42D, P{Ubi-
GFP(S65T)nls}/CyO males with yw; P{neoFRT}42D,GMR-hid2R,CL2R,y+/CyO; EGUF virgins, respectively. Double 
immunofluorescence on eye-antennal imaginal discs with anti-ISWI (DEURING et al. 2000) and anti-GFP (Abcam #5450) 
antibodies were conducted according to standard protocols (SULLIVAN et al. 2000). 
 
Adult eyes histology: Retina from ISWI-EGUF adults FRT42D, ISWI2 / FRT42D, GMR-hid; EGUF/+ were sectioned, 
processed and analyzed according to (MONTRASIO et al. 2007). 
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FIGURE S1.–Adult eye structures and double immunostaining, with anti-ISWI (red) and anti-GFP (green), of eye-antennal 
imaginal discs derived from FRT42D, GFPnls / CyO (A,B), FRT42D, GFPnls/FRT42D, GMR-hid, CL2R; EGUF/+ (C,D) and 
FRT42D, ISWI2, GFPnls/FRT42D, GMR-hid, CL2R; EGUF/+ larvae (E,F). The GFPnls allele produces an ubiquitously expressed 
nuclear localized GFP. Arrowhead indicates small dying clones with only one copy of GFPnls. Eye discs where ey-GAL4, UAS-Flp 
(EGUF) induced mitotic recombination and GMR-hid expression has occurred showed a near complete loss of ISWI signal and a 
homogenous GFP staining (E & F), suggesting that ISWI-EGUF eyes are very likely composed exclusively of homozygous ISWI2 
cells.  
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FIGURE S2.–Ommatidia organization is visualized by tangential sections through wild type (A) or ISWI-EGUF eyes (B). Loss of 
ISWI function in the adult eyes causes defects in the retina structure associated with loss of ommatidia boundaries and 
orientation. Several ommatidia are composed by a reduced number of photoreceptors (arrowhead) or photoreceptors that are 
undergoing degeneration (arrow).  
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FIGURE S3.–Wild type male polytene chromosomes (A). Loss of ISWI activity not only causes defects on the male X 
chromosome organization in 14 days old 3rd instar larvae (B) but also extensive polytene chromosome condensation defects in the 
autosomes, when ISWI2 homozygous larvae are allowed to age for 21 days (C). The arrows point to the male X chromosome, 
showing the most extensive condensation defects (DEURING et al. 2000). The arrowheads point to autosome condensation defects, 
while the asterisks indicate chromatin hinges/breakpoints or chromatin domains that appear to be resistant to de-condensation. 
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FIGURE S4.–False positives in which the PiggyBac insertion alone or the ey-GAL4, EP combination alone behaved as modifier of 
ISWI-EGUF eye phenotypes were sorted out by secondary screens. All the ISWI-EGUF interacting genetic loci shown in Figure 3 
and listed in Table S1 passed the following secondary screens: PiggyBac and EP insertion genotypes where an ISWI-EGUF 
interaction was scored (A) were sorted according to the chromosome arm in which the interacting insertion was mapped (B). All 
the insertions, sorted by the interacting class isolated (C), were tested for their inability to interact alone in the ISWI-EGUF eye 
assay (D). We distinguished between interactions mapping chromosome 2L and 2R because ISWI lies on the 2R chromosome. 
Therefore, in the ISWI-EGUF assay the presence of the FRT42D sites produces eye with the 2R chromosome in homozygosis. 
Thus, all the interacting insertions on 2L will be dominant, while the one lying on 2R will be scored as recessive. The interaction 
classes that were not isolated, in the ISWI-EGUF screen for a specific chromosome arm, were crossed out in red. Bimodal 
interactions were screened for both the Enhancer and Suppressor secondary screens described. Ehn=Enhancer; Sup=Suppressor. 
For other details check MATERIALS AND METHODS. 
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FIGURE S5.–The GFP expression in eye-antennal discs (A, B) and salivary glands nuclei (C, D) in ISWI-EGUF  and ISWIK159R 
genetic backgrounds, respectively, does not appear to significantly change. 
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FIGURE S6.–Listed are the 12 small networks comprising ISWI genetic interactors isolated in the four different genetic screens 
analyzed: “Neuronal Morphogenesis”, the worm “Multiple Cell Fate”, the ISWI-EGUF and ISWIK159R eye screens (ANDERSEN et 
al. 2006; BURGIO et al. 2008; PARRISH et al. 2006).  
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FIGURE S7.–Representative example of the quantitative analysis done with the ModFit software on different cell cycle phases 
(A). Quantification of the cell cycle profiles shown in Figure 6 (B, D and F). Relative contribution of the PreG1 and G1, S, G2/M 
(Analyzed) data shown in Figure 6 (C, E and G). 
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TABLE S1 
ISWI-EGUF screening data 
(A) ISWI dominant modifiers have been mapped to specific gene loci combining iPCR sequencing data we generated for the PiggyBac interactors with mapping data available on 
Flybase (www.flybase.org) for the EP interacting insertions. (B) ISWI-EGUF genetic interaction classes [ Su(ISWI), En(ISWI), Bi(ISWI) ] and the intersection with the ISWIK159R screen 
are shown in separate columns for every gene locus listed. If the same gene was picked in the ISWI-EGUF and ISWIK159R screens, the details of the EP insertion and strength of 
interaction (+, ++, +++) identified in the ISWIK159R is reported. When the EP identified in the ISWI-EGUF and ISWIK159R is identical it is highlighted in light blue. The data from this 
table have been used to generate the graphs shown in Figure 3. Interestingly, few genes that in the ISWIK159R screen were isolated as enhancers were instead scored as Su(ISWI) in the 
ISWI-EGUF screen. In particular, 4 of the mutations that enhanced ISWIK159R and suppressed ISWI-EGUF eye phenotypes corresponded to different EP’s insertions (Table S1). On 
the other hand, we also found 7 EP’s enhancing ISWIK159R while suppressing ISWI-EGUF eye phenotypes. These genetic interaction differences are unlikely to be explained by 
differences in the expressivity of the eyGAL4 drivers used in the ISWIK159R and ISWI-EGUF  screens (Figure S5), and are probably due to the differences in the nature of the two ISWI 
alleles employed to generate the eye-defects used for the two different genetic screens (interfering misexpressing dominant negative ISWIK159R allele versus recessive lethal ISWI2 allele 
in homozygosis). (C) The ISWI-EGUF screen resulted in the isolation of few mutations that produced both enhancement and suppression of ISWI-EGUF eye phenotypes in the same 
progeny, that we called Bi(ISWI) or bimodal. In particular, we recovered 7 bimodal interactions only in the EP but not in the PiggyBac screen. We tested other misexpression allele 
available on Flybase for the 7 Bi(ISWI) gene loci we isolated. None of new alleles corresponding the 7 Bi(ISWI) gene loci tested gave a bimodal interaction (see ‘Other Alleles’ 
column). Males FRT42D, ISWI2 / FRT42D, GMR-hid; EGUF/Bi(ISWI) giving a bimodal interactions and behaving as En(ISWI) when re-crossed with FRT42D, GMR-hid / CyO; 
EGUF/EGUF females kept giving En(ISWI), while Su(ISWI) kept giving Su(ISWI) (see ‘Re-Cross’ column). The EP lines corresponding to the 7 Bi(ISWI) where out-crossed with the 
wild type isogenic w1118 line and independent males carrying the EP (marked with the w+)  and control males with white eyes were re-tested in the ISWI-EGUF assay (see ‘Out-Cross’ 
Column). Combining the ‘Other Allele’ and ‘Out-Cross’ data we can clearly conclude that the EP3115 maps a Su(ISWI), the EP3176 an En(ISWI), the EP3400 a Su(ISWI), the 
EP3608 an En(ISWI), while we cannot conclusively say much about EP3011, EP3239 and EP3651, probably because the two lesions were too close and did not segregate (n = 
independent males tested). 
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A 
MUTATION GENE CHR ISWI-EGUF ISWIK159R iPCR DATA 
PBacE10 PK61C 3 En(ISWI)  NNNNNNNNNNNNNNNCNNTTNANANNNGAGAGCAATATTTCNA
GAATGCATGCGTCAATTTTACGCAGANTNNNNNNNNGNGTTAA
TAAATAAATAATTAATGGGCGGNGCATTCNAAATGNAAAAGAAA
ACGCAAATAGCTTGCCCACTCGCGGCAATAACGGAACCGTGAC
TTGCAAATCGGTGAAATGAATAGGATATGCATAACTGTTTTTTC
GAAAGACCTGCAAATAATTCAAGAAAGTTCCAGAAATACCCAAA
TTTAATAGCTATCCAACATTAGGGTGACAATAACGNGTTTCAAC
AGATGCAATATATACGCAAAATCAAAGAAAAACAANCNAAACCC
GTNNNANNCTNATNATNTAAANAANAATNCNNNANCNTNNNNN
NNNNGNTAA 
PBacE24 CG4294 2R En(ISWI)  NNNNNNTNTNNCGCTNTTNNGNNNAGAGAGNNNATTTCAAGAA
TGCATGCGTCAATTTTACGCAGACTATCTTTCTAGGGTTAAATT
CGCAGTTTTGACTTGTGGTTTCTGAACTGCTGAGGTAGCCTTA
TCGTTGGTCATAGGGGAACTTGTTGTACTGCCTAGGTCTTTCT
TGGCTGGGTTGTTTACAATATTCGCCGTGCTTAACGATGCATT
GTTTTTCGGCGTTGGCTTATCAACAGTAGGCGCCTTGCTTTTG
GCAACAGGAGCAGCAGTCTTGGCCCTATATATGGATCCAATTG
CAATGATCATCATGACAGATCTGACAATGTTCAGTGCAGAGACT
CGGCTACGCCTCGTGGACTTTGAAGTTGACCAACAATGTTTAT
TCTTACCTCTAATAGTCCTCTGTGGCAAGGTCANN 
PBacF48 wun 2R Su(ISWI)  NNNNNNNNNNNNTTTCNNGGGTTATGGCAGCGAATTTTGAATT
AGACAGGGCGAAGAAGTCGCTGACAGATTTCCCTGGGCGGAAT
TACTTTATGATCCACAATTGAGACCCCGCACACGTTCGCCTGTC
ACTGGGAAATCTTATCGACGGCTTAGTCGTATCATAAGTCAATA
GGGAGGGTCTCTATGACGTTTTTACCCCCAAGAAGATAGTGCC
GCAGCACTTAGGGCCTATGGCATTATTGTACGGAATGATAAACA
TTGCCTGCATAAATTCTTTTATTATATACAGCCATAATGTCAGT
AGCAAGGGAGAAAAGGTTCAAAGTCGCAAAAAATTTATGAGAAA
CCTTTACATGAGCCTGACGTCATCGTTTATGCGTAAGCGTTTA
GAAGCTCCTACTTTGAAGAGATATTTGCGCGATAATATCTCTAA
TATTTTGCCAAATGAAGTGCCTGGTACNTCAGATGACAGTACT
GAANAGCCAGTAATGAAAAAACGTACTTACTGTACTTACTGCCC
CTCTAAAATAAGGNGAAAGGCNNNNGNATNNNGNNANNNATGN
NNNNNNTNNNTCNGNNNNNANCNNCCNANNNNN 
PBacF57 CG11652 3 En(ISWI)  NNNNNNNNNNNNNNTTCNNGGGTTAACNTAGTGGTAACATTTG
GTGTTTAAATAGTTTTCGTGCTANNNNNNNATNNNTCTGTGCA
TTGTTCGAAATTAATTTCAATATTTTAAACAATATTACTTTCACC
ATTAACAACAACAAAATATGTTTACATGCTACNCTGTTTACCAT
AAANNACAACGCCAGTTTGTTTTGCCATTTTATTGCCAATTGTT
AATTCANACCTTGATGGCNCNNNNNTATCTCTAATATTTTGCC
NAATGAANTGCCTGGNACATCACATGANNNTNCTGANNANCCA
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CNNNNNNNNTNNNNNNTTATTNANTTACTGNCCCTNNNNNNN
NNTATNNNN 
PBacF60 stg 3 En(ISWI)  NNNNNNNTTNACGTACGTCNNAATATGATTATCTTTCTAGGGT
TAAAGACACACGGTCCATCGTGTAGAGTGCTACCTGTGAATGG
ATCTCTGTGGCTGGAAGCTTTGCTCATTTAACGACATTGGCGT
CTACGTCTGCAGAACACAAAGGAGCCACGCCCCCTCCACGACC
GCCCATCCCGCCGGTGCGGCGATCATATGACTGCGGCCTATGG
CATTATTGTACGGAATGATAAACATTGCCTGCATAAATTCTTTT
ATTATATACAGCCATAATGTCAGTAGCAAGGGAGAAAAGGTTCA
AAGTCGCAAAAAATTTATGAGAAACCTTTACATGAGCCTGACGT
CATCGTTTATGCGTAAGCGTTTAGAAGCTCCTACTTTGAAGAGA
TATTTGCGCGATAATATCTCTAATATTTTGCCAAATGAAGTGCC
TGGTACATCAGATGACAGTACTGAAGAGCCAGTAATGAAAAAAC
GTACTTACTGTACTTACTGCCCCTCTAAAATAAGGCGAAAGGCA
AATGCATCGTGCAAAAAATGCAAAAAAGTTATTTGTCGAGAGCA
TAATATTGATATGTGCCAAAGTTGTTTCTGACTGACTNNN 
PBacG00 slif 3 En(ISWI)  NNNNNNNTNACGTACGTCNNAATATGATTATCTTTCTAGGGTT
AAGGTATACAATTTCTATTTCTTTGTTACTATTGGTTCTAAAGT
CTGTCATAGAATTCGTTAACTAAGAACTTGACCTTCAGAGACCA
TCTGGGCAACAGCAGTCAGAATAATATCCGTCAATTAAAGTTGT
TTTAGACGCAAATAGCACGACTAGTCTCTCTCGTTAATTACTGA
CTAGCCCAGCGACTAACCCATGCCAGCTTTCATTAATTTACCCG
TATGCATTTGAGCAATATAAAGACGCTTCCGCATCGCACCCCGC
ACAAAAGCGCGATAATATCTCTAATATTTTGCCAAATGAAGTGC
CTGGTACATCAGATGACAGTACTGAAGAGCCAGTAATGAAAAAA
CGTACTTACTGTACTTACTGCCCCTCTAAAATAAGGCGAAAGGC
AAATGCATCGTGCAAAAAATGCAAAAAAGTTATTTGTCGAGAGC
ATAATATTGATATGTGCCAAAGTTGTTTCTGACTNACTANNNN 
PBacG36alfa CG14508 3 En(ISWI)  NNNNNNNNNNNNNNNTCNAGGNNNNNANACATATCGATCGAAT
GNACTTAAAAGCTCTGCTAAACTATNTGGAAAANATCTAAGCCC
CTCTCCCTTGTGTAAGNAGTATTAANNAAGNNNGNTNNNGGNN
NNNNNNNNNANGCNGGANGNTTNNNNANNNNNNNNNCNNNNN
NCNTNNNNNNCNGNTNCNCTCNCCNNNNNNCTTANNNNNGAT
TCNNNNNANANNGNNTNNGNNNNNNNNCNNTNCCNNNNNNNN
NNNNNNNNNNNNANAAAANNNNNNNNACNNCNNCNNTNNNNA
ANNNNCNNNNNNNCCNTTATNNNNNCNNNNNNNNNNTNNNNN
ANNNNNNNNNNCATACCCNTCNNNNNNNTNNNANNNNNNNNN
NNNNCTANCNNNNANCANAANCNNNANACTNNNANNNNNCTNN
NTNCTN 
PBacG80 CG15128 2R Su(ISWI)  NNNNNNNTNACGTACGTCNNAATATGATTATCTTTCTAGGGTT
AAACAACACGTTTTACGGCTCATTATAAATGAACTAGGAAAAAC
AAAGAGCAAACAAAATAGTTTATGGAAAACCTAATAAATCATAG
GAAACGTTGAAATTTACTTTCTTTCAAAATACTGATGTTAAGCA
ACACATATCATCGAAACATATCGGACTCCTTTCAACCCACACTT
GTTTTAATCTTTATTAAATTTATAGTAAAATTAACAGCCAAGTT
W. Arancio et al. 
 
13 SI 
TTAATAACACTTTAACACTTACTTTATCAAGTTGTACACAATACT
CATTTTAAGAGCGTGAAAACGATACCCATTAGAATTTTGGCAAG
GTCTACATCGCAAAACTAGTGAATACAAGAAGCCAAAATGACGT
CGATTGTGGAGATGCCAAGGGCAAATTTAGAGGAGGCCTATGG
CATTATTGTACGGAATGATAAACATTGCCTGCATAAATTCTTTT
ATTATATACAGCCATAATGTCAGTAGCAAGGGAGAAAAGGTTCA
AAGTCGCAAAAAATTTATGAGAAACCTTTACNTGAGCCTGACGT
CATCGTTTATGCGTAAGCGTTTAGAAGCTCCTACTTTNNANANA
TATTTGCGCGATNATATCTCNAANATTNNGCCAAATGANNTGN
NCTGGNNNNTCANATNAN 
PBacG92 Cpr31A  / Pen 2L En(ISWI)  NNNNNNNNNNACGTACGTCNNAATATGATTATCTTTCTAGGGT
TAATAATTAATTTACCACATTAATTNAGCGGATTACTTCTCAAA
GAATCGAAAAACAAACAATTGAAAAAGGGACTAAATCGATTGGC
AGCAATCATCTCTAAAAAAAATTTTGTTTATTTCTGACAACCGC
ATATAAACAAAATGAAAAGAGCATTAACCGGAAATATCTGCGCA
TTTATTGCATTATTACTGATAATCGGGAGATTAAATGGTATTAG
TGCAATGATAACATATTTGCAAGCAAAAAAAAANANACAATCAA
ATTTTATATTTATAGATAGACAGATAAAATCNNTNCCTTTTATT
ANCCNNTTAANTNTTGATTTANGNGGNTATTTTTTGTCTTANN
NNATATGGATANAGCTTTACATTTNANNNCATATTNGNTGANT
NANNNNNAANNNANNNNNNNNNNNNNNNNANNNNNNNNGANN
NNG 
PBacG97 CG7420 2L En(ISWI)  NNNNNNTTNACGTACGTCNNAATATGATTATCTTTCTAGGGTT
AATTTACTTTTCCAGTTGCACCCCAACTCTTTTACAACTGCCAC
CAGTGAAATTGTGCGGCGCGATAATATCTCTAATATTTTGCCAA
ATGAAGTGCCTGGTACATCAGATGACAGTACTGAAGAGCCAGT
AATGAAAAAACGTACTTACTGTACTTACTGCCCCTCTAAAATAA
GGCGAAAGGCAAATGCATCGTGCAAAAAATGCAAAAAAGTTATT
TGTCGAGAGCATAATATTGATATGTGCCAAAGTTGTTTCTGACT
GNNNNNNNNNNNNNNAAAANNNNNNNNNNNNNNANCNNANAN
NAAAAAANANNNNNNNNGNNNNNNNANNNN 
PBacK17 CG11844 3 En(ISWI)  NNNNNNNNNNNNNNNNNNNNNNNNANNANTATCTTTCTAGGG
TTAATAAAATTGCAACACCTTCAAAATAGTTTAAATTTGTTATAC
ATTTTTAAGGTATAACTTTTCCTAAATTATTGTAAATATACATAT
ATGGTTTATTTAAGGCTGTAAATTATCAAATCCCTTTTCAAAAA
CCAACCATTGTTCAGAAAATATAAATTATATATTTTAATTTTTAC
AGATATATACTGATATTGAACCGGNAACTATCNATTGTNNNANT
GNANTTANNNNANAAACN 
PBacK18 CG3092 2R En(ISWI)  NNNNNNNNNNNANNGNACGTNNNNNNATGATTATCTTTCTAGG
GTTAAAGGGCAATCGAACTTCTGGCCCAGTTCTTTAAACTTTAA
AGCATGTGTTCNTTTAAATCANTGNCNTGGGCACCCAAATCNA
TTGNCAT 
PBacL45 CG9287 2L En(ISWI)  NNNNNNNNNNCTTTCTAGGGTTNNNTTTATGCTTCTAAACCTG
TTTATGCAAACTCAGTAATCNTATAATTATGCTATTCATAGGCG
CGATAATATCTCTAATATTTTGCCAAATGAAGTGCCTGGTACAT
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CAGATGACAGTACTGAAGAGCCAGTAATGAAAAAACGTACTTAC
TGTACTTACTGCCCCTCTAAAATAAGGCGAAAGGCAAATGCATC
GTGCNAAAAATGNAAAAANNTNNNNNNNCNNNNNNNNNNNNNN
NNNNNNNNNCNNNNNNNNNTGCNATANNNNATGCNANTTGNN
NNCTCNNTGANNCNNNNNNNNNNNNNNNNNNNNTTGCNCCCT
CTGGNATTCCTCAGGNCNTGCCNGTTTGANCNTCNCTGAAAAC
CCNNNCNNNGAATCACNTGGNGCTGATGNAGNNGNCTTGNNC
CGCNNCGNCGGTGGCCGGGTCCACCCTGTNNAATTTCNTTGN
NANNANNACNGACCCCCGNCTGCTGANTNNNNNNANNNNN 
PBacL68 Gap1 3 En(ISWI)  NNNNNNNNNNNCTTTCNNGGGTTACGGNNTTTTGCAGGTAAA
GAGGGTAAACATGAACCACAAAGNCNNNCNAATGAAATGAAGG
TAANAAGGTGACAGCTAATTTNNNNNNACNACCCGATAATCNA
NGGAAGTGCNTNACTTTCGTTCTTCNNTCNNCGCGATAATATC
NCTNNTATTTNGNNNNNTGANNNGNNGNNNACNTCNNATGAC
NNNNNNGNNNNNNNNTANNNNNNNNNNNNNNNNNNTNNNNNN
TCNNNNCNNNNNNNNANNNNGANNNNNNNCNGNTNNNNNCNN
NNNNNNNCNAANNNNCNNCNNNGNNNGNANNGNNTNCGCNNN
NCNNGNNNNNNCNNNNGNNNNNNNNNNNNNNCNNCNTNNCNN
NNNNNNNNNNAAANNNNNNNNNNNNNNNNNNNNTTTNNCNCN
CNNNNNNNNNGNCNNCNNCNNCNNNNNNNNNNNNNNNNNNNN
NNNNCNNNCNNNNNNTNNNANNTTCNTNNNNNNNNNNNN 
PBacL78 CG17593 2L En(ISWI)  NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNATGATTATCT
TTCTAGGGTTAAATGTCCTAAAACTTTTCACACTAATTAAGAAA
AAAAAACTAGGTTAAATGGTTAGTGTGCCAGTCGCGTGCAGAT
TGAAGAATAAAACGCGTTAGTGCCTTTTAGTTTGAATGCNATTC
GGTATTCCNANNNANCACACNCTTGTTAAATGNTTTNNNNNNN
NTTNTTTTANTTTNTANNNATTNNNTTCN 
PBacM04alfa E2f 3 En(ISWI)  NNNNNNNNTTACGTACGTNNCAATANGATTATCTTTCTAGGGT
TAAATATTTATAGAATTAGTATAANNNNTTAAAAAAAACAAAACA
ATAAACTTCAAAGAAGTGTCNNNNTCGACTTCCATTAAACACCC
ATACATTTTTCCTTAAAAGGCGCGATAATATCTCTAATATTTTG
CCAAATGAAGTGCCTGGTACATCAGATGACAGTACTGAAGAGC
CAGTAATGAAAAAACGTACTTACTGTACTTACTGCCCCTCTAAA
ATAAGGCGAAAGGCAAATGCATCGTGCAAAAAATGCAAAAAAGT
TATTTGTCGAGAGCATAATATTGATATGTGCCAAAGTTGTTTCT
GACTGACTANNNNNNNNANNNNNNNNANNNNNNNNNNCNNNN
NNNNNNNCNNCNNNNNNNNNNNNNNAAAATANNNNNNAAAAA
NN 
 
 
PBacN13 RpL40 / 
CG15425 
2L En(ISWI)  NNNNNNNNNNNNNNNNNNNNCNNAATATGATTATCTTTCTAGG
NTTAAAGGTATATCATATTTCGTGCTAGGTAATTAAAATAAAAA
CGAATAAAAATTTTTCTTTTCAAAAATGCTGAAAATAATATTAGA
TTCCAAAAGCTGTAATATTTTTTCAATATCCAGCTGTTTGTACT
TCTGTCTGCACTGAGCGAAAAACAGTCGACCGCAGTTGGAGCT
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CAAGTTTGGGGATGTCTGCTAACCGCCGCGCGATAATATCTCT
AATATTTTGCCAAATGAAGTGCCTGGTACATCAGATGACAGTAC
TGAAGAGCCAGTAATGAAAAAACGTACTTACTGNACTTACTGCC
CCTCTAAAATAAGGCGAAAGGNAANTNNNNNNTGCAAANNNNG
NNNNNNNNNNANNNGTCCAGANCNTAANTTTGNNNNGNGCCA
AAAANTNN 
PBacN16 CG17732 3 En(ISWI)  NNNNNNNTTNACGTACGTCNNAATATNATTATCTTTCTAGGGT
TAATGTCCGTAGTTTCGGGATCATGGNNGNCTTCNTTGGATTT
TGGATAACATGCCTCCTTCATTTTCTTANCCACGTATCGAGGAC
GACCCGAACCGATCGGAAATTTCAGCATTCGGAGATGGTACTC
ACGATTCTTGGCGTATCTAGTCAGTGTCCTTGTGCGCGATAAT
ATCTCTAATATTTTGCCAAATGAAGTGCCTGGTACATCAGATGA
CAGTACTGAAGAGCCAGTAATGAAAAAACGTACTTACTGNNCTT
ACTGNCNCTNNNNNNTAANGN 
PBacN43 CG12862 2R En(ISWI)  NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTATGATTATCTT
TCTAGGGTTAATAAACTCTCGCCGACGCTTCGCACAGGGCTTA
TGTCCTGAAAGGCGTCCTTTAATTCATTTTCCATGCACACACAC
TAGCACACACATAGTCGGACTAAAAAAACAGCGGAANANGATTA
AAAACTACTTTAATATATCNTCNTTGTCNCTCCTGCGAGCCGCG
NANGAGANCNNGANGNGNATGGNN 
PBacO02 E(Pc) 2R Su(ISWI)  NNNNNNNNNNNNNNNCNTNNNNNNNNNNNANCTTTCNNNNNN
NNNNNTTTTTNGTGCAGTNNGCANNNNNNNNNNNNNCTGTCA
GAGCTGNNNNNGCCATTTAAGANNNNNNNNNNNNNNNNNNNN
ATGCNGACAAGGTAGNNNNNGNNACNNNNNNNTNNNNNTNNN
GCNTGNGTTTTNNNNNNNNCAAANANNN 
PBacO68 chn 2R En(ISWI)  _NNNNNNNNNNNNNNTACGTNNNANTANNNTTATCTTTCTAGG
NTTAAAACCGAATCGAAGGGTTCGNNNNNNNNNNNNNGNNTTC
AATTAGTAAAATGACGGGTTANNNNNNNNNNNNNGNGGNTTCN
TCATGTGTCTACCTGGACCATGTATNGNANGCCCTCCTTCTGG
NCATATACCNCNCNCCAAACCCAAAAAAGCNNNNGNNNNNNNT
AANGANNNNCNNNGTCNNANNNNNCTCCTNNTCNTTCTTT 
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B 
MUTATION GENE CHR ISWI-EGUF ISWI K159R 
    Interaction 
EP (strength) 
EP0572 Tfb2 3 Su(ISWI)    
EP0681 slmb 3 Su(ISWI)    
EP0711 Tektin-C 3 En(ISWI)    
EP0809 Nrx-IV 3 En(ISWI)    
EP1038 Fer2LCH 3 En(ISWI) ✔  
EP1059 (++) 
EP1064 heterochromatin 3 En(ISWI)    
EP1070 heterochromatin 3 En(ISWI)    
EP1082 mura 3 En(ISWI) ✔  
EP1202 (++) 
EP1196 pum 3 En(ISWI) ✔  
EP1196 (+++) 
EP1219 NinaE 3 En(ISWI)    
EP1247 Gclm 3 En(ISWI)    
EP3002 Chd64 3 En(ISWI)    
EP3006 Crc  3 En(ISWI)    
EP3011 Doa 3 Bi(ISWI)    
EP3041 mir-282 3 En(ISWI)    
EP3059 CG13623 3 Su(ISWI)    
EP3063 CG7560 3 Su(ISWI) ✔   
EP3063 (++) 
EP3065 CG5789 3 En(ISWI)    
EP3068 CG9746 / CG8420 3 En(ISWI)    
EP3072 CG8219 3 Su(ISWI)    
EP3073 CG5180 3 Su(ISWI) ✔  
EP3073 (++) 
EP3086 mor 3 En(ISWI)    
EP3089 CG6051 3 Su(ISWI)    
EP3097 Ssdp 3 En(ISWI)    
EP3098 Eip78C 3 En(ISWI) ✔  
EP3098 (++) 
EP3115 HSRomega 3 Bi(ISWI)    
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EP3121 eRF1 3 Su(ISWI) ✔  
EP3195 (+) 
EP3135 mbc 3 Su(ISWI)    
EP3137 Madm 3 En(ISWI)    
EP3139 mir-282 3 En(ISWI)    
EP3142 MKP3 3 En(ISWI)    
EP3145 Atx2 3 En(ISWI) ✔  
EP3022 (+) 
EP3146 CG5807 3 Su(ISWI)    
EP3152 RhoGAP68F 3 En(ISWI)    
EP3166 emc 3 En(ISWI)    
EP3176 SNF4Agamma 3 Bi(ISWI) ✔  
EP3332 (++) 
EP3179 CG11873 3 Su(ISWI)    
EP3186 CG5555 / CG31475 3 Su(ISWI) ✔  
EP3186 (+) 
EP3190 osa 3 En(ISWI) ✔  
EP3190 (++) 
EP3202 CG15532 3 Su(ISWI)    
EP3207 MMS19 3 En(ISWI)    
EP3210 Jheh2 3 En(ISWI)    
EP3214 As 3 En(ISWI)    
EP3216 Lk6 3 Su(ISWI)    
EP3230 olf413 3 En(ISWI)    
EP3231 CG7430 3 Su(ISWI)    
EP3234 Patr-1 3 En(ISWI) ✔  
EP562 (+) 
EP3239 RhoL 3 Bi(ISWI)    
EP3242 blot 3 En(ISWI)    
EP3259 lark 3 Su(ISWI)    
EP3292 DNApol-delta 3 En(ISWI)    
EP3314 ttk 3 Su(ISWI) ✔  
EP3062 (++) 
EP3385 wdb 3 Su(ISWI)    
EP3400 dsd 3 Bi(ISWI)    
EP3439 Rpn9 3 En(ISWI)    
EP3476 tankyrase 3 En(ISWI)    
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EP3483 Tsp96F 3 En(ISWI)    
EP3500 Eip75B 3 En(ISWI) ✔  
EP3380 (++) 
EP3541 trx 3 Su(ISWI) ✔  
EP3541 (++) 
EP3548 GlcAT-P 3 En(ISWI)    
EP3583 Hsp27 3 Su(ISWI) ✔  
EP3583 (++) 
EP3591 exba 3 En(ISWI) ✔  
EP3591 (+) 
EP3608 cpo 3 Bi(ISWI) ✔  
EP3608 (+++) 
EP3626 mir-279 / CG31044 3 Su(ISWI)    
EP3627 eff 3 Su(ISWI)    
EP3631 sqd 3 Su(ISWI)    
EP3636 CG10426 3 En(ISWI) ✔  
EP3636 (+) 
EP3648 CG33523 3 En(ISWI)    
EP3651 LysB 3 Bi(ISWI)    
EP3653 CG6650 3 Su(ISWI)    
EP3666 CG13895 3 En(ISWI) ✔  
EP3666 (+) 
EP3675 aralar1 3 En(ISWI)    
EP3676 CG18869 3 Su(ISWI) ✔  
EP3676 (+) 
EP3684 mbf1 3 Su(ISWI) ✔  
EP3684 (++) 
EP3699 CG11033 3 Su(ISWI) ✔  
EP3471 (++) 
EP3703 poly 3 En(ISWI)    
EP3736 fax 3 Su(ISWI) ✔  
EP3355 (++) 
EP3740 Spec2 3 En(ISWI)    
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C 
MUT GENE ISWI-EGUF Other Alleles 
Re-Cross Out-Cross 
EP3011 Doa Bi(ISWI) 
P{XP}Doa-d02760 -> En(ISWI) 
P{EPgy2}Doa-EY11301 -> No Interaction 
En(ISWI) -> En(ISWI) [n=12] 
Su(ISWI) -> Su(ISWI) [n=8] 
Bi(ISWI)-w+ [n=10] 
Bi(ISWI) [n=8] 
EP3115 HSRw Bi(ISWI) P{XP}Hsrω-d02763 -> Su(ISWI) 
En(ISWI) -> En(ISWI) [n=7] 
Su(ISWI) -> Su(ISWI) [n=5] 
Su(ISWI)-w+  [n=4]   
Bi(ISWI) [n=17]  
EP3176 SNF4Ag Bi(ISWI) PBac{WH}SNF4A-f01641-> En(ISWI) 
En(ISWI) -> En(ISWI) [n=4] 
Su(ISWI) -> Su(ISWI) [n=9] 
En(ISWI)-w+  [n=2]  
Bi(ISWI) [n=13] 
EP3239 RhoL Bi(ISWI) 
PBac{WH}f02848 -> Su(ISWI) 
P{XP}d00094 -> En(ISWI) 
En(ISWI) -> En(ISWI) [n=13] 
Su(ISWI) -> Su(ISWI) [n=11] 
Bi(ISWI)-w+  [n=5] 
Bi(ISWI) [n=10] 
EP3400 dsd Bi(ISWI) P{EPgy2}EY05482 -> Su(ISWI)  
En(ISWI) -> En(ISWI) [n=9] 
Su(ISWI) -> Su(ISWI) [n=8] 
Su(ISWI)-w+  [n=9]   
Bi(ISWI) [n=12] 
EP3608 cpo Bi(ISWI) P{XP}cpo-d09064 -> En(ISWI) 
En(ISWI) -> En(ISWI) [n=3] 
Su(ISWI) -> Su(ISWI) [n=11] 
En(ISWI)-w+  [n=7]  
Bi(ISWI) [n=14] 
EP3651 LysB Bi(ISWI) 
P{XP}d11180 -> En(ISWI) 
P{XP}d01620 -> En(ISWI) 
En(ISWI) -> En(ISWI) [n=5] 
Su(ISWI) -> Su(ISWI[n=6] 
Bi(ISWI)-w+  [n=10] 
Bi(ISWI) [n=11] 
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TABLE S2 
Predicted ISWI functional connections 
Known genetic or physical interactors existing among the genes identified in the fly “Neuronal Morphogenesis” (A) and the worm “Multiple Cell Fate” (B) screens, the modifier 
genes we picked in both the ISWI-EGUF (C) and ISWIK159R  (D) eye screens (ANDERSEN et al. 2006; BURGIO et al. 2008; PARRISH et al. 2006) and the “Connecting” nodes (E). This 
table contains the raw data used to compose Figure 5. 
 
A 
Fly Gene Description GO Special 
aop anterior open ;transport;transcription;signal transduction; 
asf1 anti-silencing factor 1 ;DNA metabolic process; 
ato atonal ;transcription;signal transduction;cell cycle; 
bap55 Brahma associated protein 55kD ;protein catabolic process;cell organization and biogenesis; 
bap60 Brahma associated protein 60kD ;DNA metabolic process; 
brm brahma ;DNA metabolic process;transcription; 
CG4328 CG4328 NONE 
Tab2 Tab2 NONE 
ci cubitus interruptus ;signal transduction; 
dpn deadpan ;transcription; 
E(z) Enhancer of zeste ;metabolic process;transcription;DNA metabolic process; 
esc extra sexcombs ;metabolic process;DNA metabolic process;signal transduction;transcription; 
EcR Ecdysone receptor ;autophagy;signal transduction;transcription;metabolic process; 
gro groucho ;transcription;cell organization and biogenesis;signal transduction; 
kni knirps ;transcription;signal transduction; 
M8 Enhancer of split ;transcription;signal transduction; 
RpS29 Ribosomal protein S29 ;translation; 
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run CG1849-PA ;transcription; 
scrt scratch NONE 
sens senseless ;transcription;signal transduction; 
sna snail NONE 
snr1 Snf5-related 1 ;DNA metabolic process; 
Stat92E 
Signal-transducer and activator of transcription 
protein at 92E ;signal transduction;transcription; 
Su(z)12 Su(z)12 ;metabolic process;transcription;DNA metabolic process; 
tgo tango ;transcription;metabolic process;signal transduction; 
trap36 Mediator complex subunit 4 NONE 
fd3f forkhead domain 3F NONE 
cg2678 CG2678 ;transcription; 
Elongin-C Elongin C ;transcription; 
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B 
Worm Gene Fly Gene Description GO Special 
smo-1 smt3 smt3 ;protein transport;metabolic process; 
lin-53 Caf-1 Chromatin assembly 
factor 1 subunit 
;DNA metabolic process;metabolic process;transcription;DNA repair; 
dpl-1 Dp DP transcription factor ;cell cycle;transcription; 
efl-1 E2f E2F transcription factor ;DNA replication;transcription; 
lin-35 Rbf1 Retinoblastoma-family 
protein 
;DNA replication;cell cycle;transcription;DNA metabolic process; 
lin-13 CG7987 CG7987 ;metabolic process;transcription; 
ssl-1 dom domino ;DNA replication;DNA metabolic process;response to DNA damage stimulus;DNA 
repair;metabolic process;DNA recombination; 
epc-1 E(Pc) Enhancer of Polycomb ;DNA metabolic process; 
gap-1 Gap1 GTPase-activating 
protein 1 
;signal transduction; 
hpl-2 HP1b HP1b ;DNA metabolic process; 
let-418 Mi-2 Mi-2 ;DNA metabolic process;transcription;metabolic process; 
lin-8 Map60 Microtubule-associated 
protein 60 
;cell organization and biogenesis; 
hda-1 Rpd3 Rpd3 ;metabolic process;transcription;DNA metabolic process; 
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C 
Fly Gene Description GO Special 
mor moira ;DNA metabolic process; 
dsd distracted NONE 
stg string ;cell cycle;protein amino acid dephosphorylation; 
CG11652 CG11652 NONE 
CG11798 charlatan ;transcription; 
eff effete ;metabolic process;cell organization and biogenesis;cell cycle; 
Lk6 Lk6 ;signal transduction;cell organization and biogenesis;protein amino acid phosphorylation; 
CG8219 CG8219 ;protein transport; 
fray frayed ;metabolic process;signal transduction;protein amino acid phosphorylation; 
HSRomega Heat shock RNA omega goProcess 
olf413 olf413 nuclear speck organization and biogenesis;response to heat;oogenesis (sensu Insecta);protein localization; 
RhoGAP68F RhoGAP68F histidine catabolic process;catecholamine metabolic process;synaptic transmission; 
mbc myoblast city cytoskeleton organization and biogenesis;cell motility;intracellular signaling cascade; 
CG31475 CG31475 phagocytosis;intracellular signaling cascade;intracellular protein transport;cell morphogenesis;larval visceral muscle 
development;striated muscle development;myoblast fusion;mesoderm development;dorsal closure; 
CG8669 CG8669-PA, isoform A calcium-mediated signaling; 
NinaE neither inactivation nor 
afterpotential E 
molting cycle (sensu Insecta);regulation of transcription, DNA-dependent;regulation of 
transcription;pupation;pupariation;metamorphosis (sensu Insecta); 
sqd squid rhabdomere development;adult locomotory behavior;G-protein coupled receptor protein signaling 
pathway;phototransduction;visual perception;sensory perception;protein-chromophore linkage;signal transduction;photoreceptor 
cell morphogenesis (sensu Endopterygota); 
CG4799 Pendulin RNA export from nucleus;oocyte localization during oogenesis;mRNA catabolic process, nonsense-mediated decay;dorsal/ventral 
axis determination, follicular epithelium (sensu Insecta);follicle cell migration (sensu Insecta);oocyte anterior/posterior axis 
determination (sensu Insecta);egg chamber formation (sensu Insecta);intracellular mRNA localization;regulation of alternative 
nuclear mRNA splicing, via spliceosome;oogenesis (sensu Insecta);pole plasm mRNA localization;negative regulation of 
translation;pole plasm oskar mRNA localization;oocyte microtubule cytoskeleton organization (sensu Insecta);dorsal/ventral pattern 
formation;mRNA export from nucleus; 
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D 
Fly Gene Description GO Special 
trbl tribbles ;signal transduction;protein amino acid phosphorylation; 
pnut peanut ;cell organization and biogenesis;cell cycle; 
tara taranis ;DNA metabolic process; 
kis kismet ;DNA metabolic process; 
Dip3 Dorsal interacting protein 3 NONE 
CG12284 thread ;metabolic process; 
CG7231 CG7231 NONE 
csw corkscrew ;signal transduction;protein amino acid dephosphorylation; 
ptc patched ;metabolic process;protein catabolic process;signal transduction; 
CG30497 CG30497 NONE 
RhoBTB RhoBTB ;signal transduction;protein transport;cell cycle;cell organization and biogenesis; 
fax failed axon connections NONE 
argos argos ;cell organization and biogenesis; 
mbf1 multiprotein bridging factor 1 NONE 
EP3208 bantam NONE 
Sin3A Sin3A ;metabolic process; 
tkv thickveins ;signal transduction;protein amino acid phosphorylation; 
Ras85D Ras oncogene at 85D ;signal transduction;transport;cell organization and biogenesis;protein transport; 
spin spinster ;transport; 
CtBP C-terminal Binding Protein ;metabolic process; 
Act42A Actin 42A ;cell organization and biogenesis; 
Rm62 Rm62 ;metabolic process; 
Cdk4 Cyclin-dependent kinase 4 ;cell cycle;signal transduction;cell organization and biogenesis;protein amino acid phosphorylation; 
Acf1 ATP-dependent chromatin assembly 
factor large subunit 
;DNA metabolic process; 
abl Abl tyrosine kinase ;cell organization and biogenesis;signal transduction;protein amino acid phosphorylation; 
GlyP Glycogen phosphorylase ;carbohydrate metabolic process; 
Hsp27 Heat shock protein 27 ;response to stress;metabolic process; 
DNAJ-1 DnaJ-like-1 ;response to stress;metabolic process; 
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ttk tramtrack ;transcription;DNA metabolic process; 
eas easily shocked ;metabolic process; 
CG6353 CG6353 NONE 
osa osa ;transcription;signal transduction;DNA metabolic process; 
Alh CG1070-PC, isoform C NONE 
lolal lola like ;DNA metabolic process; 
trx trithorax ;DNA metabolic process;transcription;metabolic process; 
dan distal antenna NONE 
spi spitz ;cell cycle;signal transduction; 
shn schnurri ;transport;signal transduction; 
pAbp polyA-binding protein ;metabolic process;RNA processing; 
bhr bhringi NONE 
Fmr1 Fmr1 ;metabolic process;transport; 
E(bx) Enhancer of bithorax ;DNA metabolic process;transcription;signal transduction; 
Hsc70-4 Heat shock protein cognate 4 ;transport;metabolic process;response to stress; 
eRF1 eukaryotic release factor 1 ;protein transport;signal transduction;translation; 
Pros25 Proteasome 25kD subunit ;protein catabolic process; 
CG33967 CG33967 NONE 
CG33967 CG33967 NONE 
CG11324 homer ;signal transduction; 
nuf CG33991-PC, isoform C ;cell organization and biogenesis; 
Elongin-B Elongin B ;metabolic process; 
CG5466 CG5466 NONE 
Pk17E Protein kinase-like 17E ;cell cycle;signal transduction;protein amino acid phosphorylation; 
CG9520 CG9520 ;metabolic process; 
Atg1 Autophagy-specific gene 1 ;protein amino acid phosphorylation;signal transduction;autophagy; 
CG3885 CG3885 ;transport;protein transport; 
ld14 ld14 NONE 
CG10346 Grip71 NONE 
Rac2 Rac2 ;signal transduction;cell organization and biogenesis;RNA localization;protein transport; 
RpL19 Ribosomal protein L19 ;translation; 
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CG11033 CG11033 ;metabolic process;protein catabolic process; 
mub mushroom-body expressed ;signal transduction;RNA processing;protein transport;metabolic process;transcription; 
CG8144 pasilla ;RNA processing; 
CG5180 CG5180 NONE 
CG17161 grapes ;response to DNA damage stimulus;cell cycle;signal transduction;cell organization and biogenesis;DNA metabolic 
process;protein amino acid phosphorylation; 
Dap160 Dynamin associated protein 160 ;transport;protein transport; 
CG14478 CG14478 ;DNA metabolic process; 
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E 
Fly Gene Description GO Special 
Arc105 Mediator complex 
subunit 15 
NONE 
cenG1A centaurin gamma 1A ;signal transduction; 
CG1855 CG11138 NONE 
CG2540 CG2540 NONE 
gus gustavus ;signal transduction; 
CG4641 CG4641 NONE 
CG5731 CG5731 ;carbohydrate metabolic process; 
CG7379 CG7379 ;cell cycle; 
CG9331 CG9331 ;metabolic process;carbohydrate metabolic process; 
omd oocyte maintenance 
defects 
NONE 
CG11248 CG11248 ;protein transport;cell cycle; 
CG11449 CG11449 NONE 
CG13510 CG13510 NONE 
CG14089 CG14089 ;transport; 
CG14425 CG14425 NONE 
CG14982 CG14982 NONE 
CG15006 CG15006 NONE 
CG15167 CG15167 NONE 
CG15634 CG15634 NONE 
CG16719 CG16719 NONE 
CG17159 CG40460-PC.3 NONE 
CG17508 CG17508 NONE 
CG31679 CG31679 NONE 
dei delilah NONE 
W. Arancio et al. 
 
28 SI 
E5 E5 NONE 
gt giant ;transcription;signal transduction; 
heph hephaestus ;RNA processing;signal transduction; 
Hil Hillarin NONE 
His3.3A Histone H3.3A ;DNA metabolic process; 
CG11275 CG11275 NONE 
klar klarsicht ;cell organization and biogenesis; 
lwr lesswright ;metabolic process;protein transport; 
Mtl Mig-2-like ;signal transduction;cell cycle;cell organization and biogenesis; 
PHDP Putative 
homeodomain 
protein 
NONE 
ple pale ;metabolic process;signal transduction; 
pnr pannier ;transcription;signal transduction;metabolic process; 
Poxm Pox meso ;signal transduction;transcription; 
RpS18 Ribosomal protein 
S18 
;translation; 
SP59 CG11824 ;protein catabolic process; 
squ squash NONE 
Rac1 Rac1 ;signal transduction;cell organization and biogenesis; 
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TABLE S3 
Some of the predicted interacting nodes genetically interacts with ISWI 
Alleles corresponding to genes picked in the fly “Neuronal Morphogenesis” (A) and the worm “Multiple Cell Fate” (B) screens and the “Connecting” nodes (C), genetically 
interacted with the ISWI-EGUF or the  ISWIK159R  eye assays. ISWI-EGUF  and ISWIK159R  genetic interaction classes are shown in separate columns for every gene locus listed.  
A 
Gene Cyto Map Allele Stock ISWI-EGUF ISWIK159R 
asf1 76B9-76B9 Asf1
1 9547 (Bloom) En(ISWI) - 
brm 72C1-72C1 brm
2 3619 (Bloom) - - 
    brm
2 3622 (Bloom) - - 
E(z) 67E5-67E5 E(z)
EY21318 22471 (Bloom) - - 
gro 96F10-96F10 gro
1 511 (Bloom) En(ISWI) ++ 
    groDG12307 20592 (Bloom) Su(ISWI) - 
kni 77E3-77E3 kni
10 3307 (Bloom) - - 
    kniri-1 566 (Bloom) - - 
    knid10922 19340 (Bloom) En(ISWI) - 
sens 70A8-70A8 sens
E2 5311 (Bloom) En(ISWI) ++ 
    sensLy-1 8136 (Bloom) - ++ 
    sensf06181 18946 (Bloom) - - 
snr1 83A4-83A4 Snr1
01319 11529 (Bloom) En(ISWI) - 
Stat92E 92F1-92F1 Stat92E
06346 11681 (Bloom) En(ISWI) - 
  Stat92EDG17607 21574 (Bloom) En(ISWI) - 
  
  Stat92EHJ 24510 (Bloom) En(ISWI) - 
Su(z)12 76D4-76D4 Su(z)
123 5068 (Bloom) En(ISWI) ++ 
tgo 85C2-85C2 tgo
1 9588 (Bloom) En(ISWI) ++ 
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    tgoEY03802 15914 (Bloom) - - 
EcR 42A9-42A12 EcR
06410 11770 (Bloom)   - 
aop 22D1-22D1 aop
03953a 11359 (Bloom)   - 
    aop1 3101 (Bloom)   - 
    aopyan-XE18 8777 (Bloom)   - 
Tab2 56C8-56C9 Tab2
201Y 4440 (Bloom)   ++ 
esc 33A2-33A2 esc
1 813 (Bloom)     
    esc21 3623 (Bloom)     
Elongin-C 56D7-56D7 Elongin-C
e01107 17924 (Bloom)     
Bap55 54B7-54B7 Bap55
EY15967 21174 (Bloom)   +++ 
sna 35D2-35D2 sna
18 2311 (Bloom)     
    sna19 101332 (DGRC)     
run 19E2-19E2 run
2 8128 (Bloom)   + 
    run3 4496 (Bloom)     
    run29 4497 (Bloom)   + 
ci 102A1-102A3 ci
1 642 (Bloom)   + 
    ci36  643 (Bloom)   +++ 
    ci57 644 (Bloom)   + 
    ciW 646 (Bloom)     
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B 
Gene  Cyto Map Allele Stock ISWI-EGUF ISWIK159R 
Caf-1 
88E3-88E3 
Caf1DG25308 21275 (Bloom) En(ISWI) + 
E2f 
93E9-93F1 
E2f07172 11717 (Bloom) En(ISWI) 
++ 
  
  
E2fi2 7274 (Bloom) En(ISWI) ++ 
CG7987 
88C6-88C6 
CG7987EY22125 22538 (Bloom) En(ISWI) - 
Gap1 67C10-67C11  Gap1EY00011 14996 (Bloom) - + 
Mi-2 
76D3-76D4 
Mi-2S000606 l(3)S000606 (Szeg) - - 
Rpd3 64B12-64B12  
Rpd304556 
11633 (Bloom) 
En(ISWI) 
+++ 
smt3 
27C7-27C7 
smt304493 11378 (Bloom) 
  
+ 
Map60 
45F5-45F6 
Map60KG00506 14880 (Bloom) 
  
++ 
dom 
57D11-57D12 
dom9 9261 (Bloom) 
  
- 
    domEY01281 15337 (Bloom) 
  
+ 
E(Pc) 
47F13-47F14 
E(Pc)EP608 17286 (Bloom) 
  
+ 
Rbf 
1C5-1C5 
Rbf14 7435 (Bloom) 
  
- 
    RbfEY07209 16803 (Bloom) 
  
+ 
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C 
Gene  Cyto Map Allele Stock ISWI-EGUF ISWIK159R 
CG7379 
90C5-90C5 
CG7379 14430 (Bloom) En(ISWI) +++ 
dei 
97B2-97B2 
deie01478 17955 (Bloom) - - 
heph 
100D3-100E1 
heph2 635 (Bloom) En(ISWI) - 
    hephPL00536 19538 (Bloom) - - 
klar 
61C1-61C3 
klar1 3330 (Bloom) - - 
Mtl 
98A13-98A13 
MtlEP855 17297 (Bloom) En(ISWI) 
++ 
    Mtlf07113 19043 (Bloom) - + 
    MtlΔ 6679 (Bloom) - - 
ple 
65C3-65C3 
ple4 3279 (Bloom) - - 
    plef01945 18492 (Bloom) - + 
pnr 
89A13-89B1 
pnr1 3106 (Bloom) - - 
  
  
pnrMD237 3039 (Bloom) En(ISWI) - 
Rac1 
61F5-61F5 
Rac1J10 6679 (Bloom) - - 
CG5731 
31B1-31B1 
CG5731KG05192 13881 (Bloom) 
 
- 
CG9331 
38F1-38F1 
CG9331EY06494 16397 (Bloom) 
  
+ 
cenG1AE  34D6-34E2 cenG1AEY10943  20232 (Bloom) 
  
- 
squ 
36A10-36A10 
squPP32 5114 (Bloom) 
  
+ 
gt 
3A3-3A3 
gtX11 1530 (Bloom) 
  
- 
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CG14425-Sxl 6F3-6F5 CG14425-Sxl 17354 (Bloom) 
  
+ 
 
 
 
